Today's Stock News: Latest Updates on Public Companies
755 news published.
EARNINGS & GUIDANCE
The Home Depot (HD) reported Q1 fiscal 2026 results and reaffirmed full‑year guidance, providing a steady read on consumer home‑spend and inventory management for retailers and suppliers.
Bilibili (BILI) published Q1 2026 results; user growth and monetization remain key to China‑tech sentiment amid regulatory scrutiny.
GitLab (GTLB) set a date to announce first‑quarter fiscal 2027 results, a datapoint investors watch for ARR and gross‑margin progress.
CAVA Group (CAVA) released Q1 results, where sales and margin trends offer a snapshot of consumer dining and off‑premise demand.
Toll Brothers (TOL) posted FY26 Q2 results; backlog and order cadence remain the main housing indicators to watch.
James Hardie (JHX) reported Q4 FY26 and full‑year results with FY27 outlook, useful for gauging pricing power in building materials.
BIG TECH, AI & INFRASTRUCTURE
Apple (AAPL) rolled out new accessibility features tied to Apple Intelligence; the announcement underscores how AI is being embedded across hardware and services to boost engagement and recurring revenue.
Dell Technologies (DELL) unveiled PowerStore Elite, aiming to reshape enterprise storage economics for AI and mixed workloads.
Analog Devices (ADI) agreed to acquire Empower Semiconductor, strengthening power‑management capabilities that matter for data‑center and AI accelerator designs.
Keysight Technologies (KEYS) posted Q2 2026 results, a demand signal for semiconductor test tied to AI chip scaling and 5G rollouts.
NextNav (NN) demonstrated a wireless indoor timing solution for critical infrastructure—timing indoors has implications for telecom, utilities and 5G resiliency.
AEye (LIDR) signed an MOU with MoveAWheeL to combine long‑range lidar and real‑time road‑surface friction sensing, a commercial step for safety systems in vehicles and ADAS suppliers.
HEALTHCARE & BIOTECH
Hansa Biopharma (HNSA) struck a €115M licensing deal for IDEFIRIX in Europe and MENA, de‑risking regional commercial exposure and cash flow visibility.
Valion Bio (VBIO) briefed senior Department of War and BARDA officials on entolimod for acute radiation syndrome in a joint engagement; involvement of BARDA/DoD can accelerate development and support funding pathways for biodefense candidates.
Monopar (MNPR) announced publication of a Phase 2 study showing ALXN1840 significantly improves copper balance in Wilson disease—data that can affect regulatory and partnering prospects.
IGC Pharma (IGC) reported Q1 2026 results and said CALMA Phase 2 is ~80% enrolled, a progress update investors track for milestone timing.
Relay Therapeutics (RLAY) filed for a proposed stock offering after early Zovegalisib data; dilution versus program upside will be weighed by investors.
Eton Pharmaceuticals (ETON) expanded its rare‑disease portfolio with U.S. rights to IMPAVIDO® (miltefosine), bolstering specialty sales potential. Details.
DEFENSE, AEROSPACE & INDUSTRIALS
Boeing (BA) drew scrutiny over reliance on Chinese rare‑earth magnets for U.S. military drone production, a reminder that geopolitics reshape defense supply chains and reshoring discussions.
GE Aerospace (GE) won a U.S. Air Force contract to advance the GE426 engine for an autonomous collaborative platform, supporting long‑cycle aerospace revenue visibility.
ENERGY, CLEAN TECH & MATERIALS
Anaergia (AMRC) secured a C$58M contract with Neogenyx Fuels to expand RNG deployment, strengthening backlog and multiyear revenue visibility in decarbonization infrastructure. Contract.
Shoals Technologies Group (SHLS) opened a new Tennessee mega‑facility to support U.S. manufacturing of solar balance‑of‑system components, easing supply constraints for project developers.
Celanese (CE) announced an engineered‑materials price increase, an input to margin modeling across downstream industrials and auto suppliers.
M&A, CAPITAL MARKETS & CORPORATE ACTIONS
AIG (EG) agreed to acquire Everest’s insurance operations in Colombia, expanding Latin America underwriting reach. Details.
Bank First Corporation (BFC) signed an agreement to acquire PSB Holdings, a regional consolidation move that boosts scale and local deposit franchises. Announcement.
Paramount Skydance (PSKY) launched a complex capital action: an offer to purchase and exchange existing Discovery notes as it reshapes debt ahead of integration—important for investors tracking media consolidation and leverage.
S&P Global (SPGI) announced pricing of a $2.0B private offering of senior notes by Mobility Global Inc. ahead of a planned separation, a large capital markets move tied to corporate carve‑out planning. Terms.
Trinity Capital (TRIN) priced $300M of 7.0% notes due 2031, a funding action that affects its leverage profile and yield curve exposure for specialty finance investors. Details.
Inno Holdings (INHD) launched a $60M ATM equity program, a flexible capital tool that can dilute shares if used but supports growth or balance‑sheet needs.
Neptune Insurance Holdings (NP) said underwriters fully exercised an option to purchase additional shares in its offering, signaling stronger-than-expected demand for the follow‑on. Notice.
Roblox (RBLX) announced an inaugural buyback, a capital‑allocation shift investors will weigh against reinvestment in product and growth.
STRATEGIC PARTNERSHIPS & COMMERCIAL WINS
QIAGEN (QGEN) and NVIDIA teamed on graph‑based AI to speed drug discovery—an example of compute partnerships lifting biotech R&D efficiency.
Dell's PowerStore push and Analog Devices's tuck‑in both show hardware vendors positioning to capture AI‑related enterprise spending across servers, storage and power subsystems.
WHAT TO WATCH NEXT
- Integration and margin targets following the ADI/Empower deal.
- How the Mobility Global debt placement affects S&P Global’s separation timetable and credit profile.
- Consumer spending cues from retail and restaurants, including early reads at CAVA and Home Depot.
- BARDA/DoD engagement and biodefense funding flows after Valion Bio’s briefing; such involvement can speed development and procurement pathways.
- Biotech milestones and capital needs, highlighted by enrollment progress at IGC Pharma and Monopar’s published Phase 2 results for Wilson disease (study).
Don't miss out on market-moving news. Bookmark this page and check back regularly for the most recent updates on stocks, sectors, and the overall market landscape. Stay informed, stay ahead, and make smarter investment choices with our comprehensive stock news coverage.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement